Motus gi appoints experienced financial biotech executive, sonja nelson, to its board of directors and as chair of audit committee

Fort lauderdale, fla., june 23, 2021 (globe newswire) -- motus gi holdings, inc. , (nasdaq: mots) ("motus gi" or the "company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced the appointment of sonja nelson, cpa to the company's board of directors and as chair of the audit committee. ms. nelson brings more than 25 years of financial and operational leadership and expertise in biotechnology, diagnostics, and biopharmaceuticals markets, including playing an integral role in the successful merger between nantkwest, inc. (nasdaq: nk) and immunity bio, inc. (nasdaq: ibrx).
MOTS Ratings Summary
MOTS Quant Ranking